Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Liverpool Featured PhD Programmes
University of Oxford Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Hong Kong Featured PhD Programmes
University College London Featured PhD Programmes
"leukaemia"×
10 miles

leukaemia PhD Projects, Programs & Scholarships

We have 24 leukaemia PhD Projects, Programs & Scholarships

  • "leukaemia" ×
  • clear all
Order by 
Showing 1 to 10 of 24
  Defining the ‘molecular signature’ of PARP inhibitor sensitivity in blood cancers
  Dr T Gaymes
Applications accepted all year round
Despite significant advances in the understanding of the biology of blood cancers, identification of the most effective and safe form of treatment continues to present a formidable challenge to clinicians.
  Development of targeted therapy for acute myeloid leukaemia with mutations in isocitrate dehysdrogenase
  Dr L. Kats
Applications accepted all year round
Acute Myeloid Leukaemia (AML) is an aggressive disease with poor prognosis and development of novel treatment options is urgently needed.
  Cancer and ageing: studying leukaemia & blood stem cell exhaustion in short-lived African killifish
  Dr E Payne, Prof J Bahler, Dr G Stefani
Application Deadline: 14 December 2018
Cancer is overwhelmingly a disease of the elderly, and age is its largest risk factor. Clonal, age-associated populations of haematopoietic cells have been found in large numbers of haematopoietically normal humans.
  Understanding the role of the Guanosine Trimethylase TGS1 in Acute myeloid leukaemia
  Dr I Barbieri
Application Deadline: 3 January 2019
RNA methylation is a reversible post-translational modification to RNA that epigenetically numerous biological processes. The biological and molecular functions of RNA methylation are generally very poorly understood, both in normal and pathological biological processes.
  Epigenetics and Cancer: Development of Novel Tools to Determine how Aberrant V(D)J Recombination Reactions Cause Leukaemia
  Research Group: School of Molecular and Cellular Biology
  Dr J Boyes
Applications accepted all year round
V(D)J recombination generates a highly diverse set of immunoglobulin and T cell receptor genes to enable vertebrates to fight a vast range of infections.
  Normal and Leukaemic Haemopoiesis: Understanding the fundamental biological processes underlying normal and malignant haematopoiesis and translate this to improve patient outcomes through new rational therapies.
  Dr P Vyas, Prof Claus Nerlov, Prof I Roberts
Application Deadline: 11 January 2019
Understanding the fundamental biological processes underlying normal and malignant haematopoiesis and translate this to improve patient outcomes through new rational therapies.
  ChromDesign-ITN: Chromatin topology studies in mouse ES and human leukemia cell lines (subproject ESR13); Hosting institution: Diagnose, Liege, Belgium
  Dr Celine Sabatel, Prof MariaElena orres-Padilla
Application Deadline: 21 December 2018
"ChromDesign” is a European innovative and interdisciplinary Research and Training network, which aims to characterize the impact of the 3D chromatin organization on gene regulation during cellular differentiation and in several human disorders, and to train junior researchers in the biomedical field, either in academia or in the private sector.
  Establishing the potential of GSK3 manipulation for the treatment of human leukaemias
  Dr C Sutherland, Dr S Tauro
Applications accepted all year round
Background. Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in the Western world.
  Investigating the modulation of cellular responses as a consequence of long term Poly ADP Ribose Polymerase (PARP) inhibition therapy
  Dr T Gaymes
Applications accepted all year round
Approximately 30 years ago, Poly ADP Ribose Polymerase (PARP) activity was shown to play a critical role in the processes of DNA repair in nucleated cells.
  Epigenetic mechanisms in CD5+ malignant B lymphocytes
  Research Group: Centre for Experimental Medicine
  Dr E Kostareli, Prof K Mills
Application Deadline: 20 January 2019
B-cell receptor (BCR) signalling is a complex molecular network critical for normal B-cell development and function. Among the numerous proteins of BCR pathway, Bruton tyrosine kinase (BTK) has gained significant attention over the last decade.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.